Tuesday, November 5, 2019

Sun Pharma & AstraZeneca enter license agreement for novel oncology products in China

The agreement will help to bring costeffective and quality drugs to patients in China.

from India Infoline News Service https://ift.tt/2PXndER
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)